US judge dismisses Mylan suit over Lipitor generic

WASHINGTON, May 2 (Reuters) - A U.S. judge on Monday dismissed an attempt by Mylan Inc to speed up getting its generic version of Pfizer Inc's blockbuster cholesterol-lowering drug Lipitor on the market and block an exclusive for a generic by India's Ranbaxy .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.